Auf dieser Seite
NUVB Klasse A Nuvation Bio Inc. Class A Common Stock
NYSE · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ 10-K/10-Q Aug 6, 2026
$4,57
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,9252-Wochen-Tief
$9,7552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.58B
P/E (TTM)
-10.4
EPS (TTM)
$-0.44
Umsatz (TTM)
$170M
Ihre Abzeichen
52W-Spanne
$4–$10
Analystenbewertung
BUY
Kursziel
$13
P/E
-10.4
ROE
-47.8%
Nettogewinnmarge
-88.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
NUVB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.57
Marktkapitalisierung (MRQ)
$1.58B
P/E (TTM)
-10.4
EPS (TTM)
$-0.44
Umsatz (TTM)
$170M
ROE (TTM)
-47.8%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$4–$10
NUVB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$63M2023-12-31 → 2025-12-31
EPS$-0.602021-12-31 → 2025-12-31
Nettogewinnmarge-88.2%2024-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | NUVB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -10.45-Jahres-Durchschnitt ≈-8.8 | ≈-8.8 | · | · | |
| P/S (TTM) | 9.3 | · | 11.6 | Fairer Wert | |
| K/B (MRQ) | 6.25-Jahres-Durchschnitt ≈3.7 | ≈3.7 | 4.1 | Überbewertet | |
| EV / EBITDA | -5.0 | · | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -9.15-Jahres-Durchschnitt ≈-14.0 | ≈-14.0 | · | · | |
| EV / Umsatz (TTM) | 5.5 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 6.55-Jahres-Durchschnitt ≈3.2 | ≈3.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | NUVB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -81.0% | · | -62.9% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -338.7% | · | -29.4% | Schwach | |
| Vorgewinnmarge (TTM) | -88.2% | · | -18.0% | Schwach | |
| Nettogewinnmarge (TTM) | -88.2% | · | -59.2% | Schwach | |
| ROA (TTM) | -21.5%5-Jahres-Durchschnitt ≈-41.4% | ≈-41.4% | -10.3% | Schwach | |
| ROE (TTM) | -47.8%5-Jahres-Durchschnitt ≈-51.3% | ≈-51.3% | -12.6% | Schwach | |
| ROIC | -68.4%5-Jahres-Durchschnitt ≈-56.3% | ≈-56.3% | -14.8% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | NUVB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.0 | · | 0.4 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 8.45-Jahres-Durchschnitt ≈28.1 | ≈28.1 | 10.7 | Unterdurchschnittlich | |
| Quick Ratio | 6.45-Jahres-Durchschnitt ≈27.6 | ≈27.6 | 9.9 | Unterdurchschnittlich |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | NUVB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 699.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | NUVB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.1 | · | 0.3 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$206.2K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
1.7%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.15 | $-0.19 | 20.6% |
| 31. März 2026 | Mai 19, 2026 | $0.01 | $0.01 | — |
| 31. Dezember 2025 | $-0.11 | $-0.09 | -20.7% | |
| 30. September 2025 | $-0.16 | $-0.17 | 7.0% | |
| 30. Juni 2025 | $-0.17 | $-0.17 | 0.87% | |
| 31. März 2025 | $-0.16 | $-0.16 | 0.93% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $63M | $8M | $0 | |
| Cost of Revenue | · | $7M | $0 | |
| Gross Profit | · | $795.0K | $0 | |
| R&D Expense | $115M | $99M | $71M | |
| SG&A Expense | $152M | $69M | $29M | |
| Operating Expenses | $276M | $600M | $100M | |
| Operating Income | $-213M | $-593M | $-100M | |
| Other Non-op | $2M | $-109.0K | $24M | |
| Pretax Income | $-205M | $-568M | $-76M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-205M | $-568M | $-76M | |
| EPS (Basic) | $-0.60 | $-2.11 | $-0.35 | |
| EPS (Diluted) | $-0.60 | $-2.11 | $-0.35 | |
| Shares (Basic) | 341,541 | 268,772 | 218,880 | |
| Shares (Diluted) | 341,541 | 268,772 | 218,880 | |
| EBITDA | $-213M | $-593M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $164M | $36M | $43M | |
| Short-term Investments | $365M | $467M | $569M | |
| Inventory | $11M | $0 | · | |
| Prepaid Expense | $12M | $7M | $2M | |
| Current Assets | $572M | $526M | $616M | |
| PP&E (Net) | $564.0K | $586.0K | $717.0K | |
| PP&E (Gross) | $2M | $1M | $1M | |
| Accum. Depreciation | $1M | $874.0K | $666.0K | |
| Intangibles | $11M | $5M | $0 | |
| Other Non-current Assets | $8M | $7M | $587.0K | |
| Total Assets | $595M | $541M | $621M | |
| Accounts Payable | $9M | $6M | $2M | |
| Accrued Liabilities | $45M | $33M | $10M | |
| Short-term Debt | $6M | $6M | $0 | |
| Current Liabilities | $82M | $58M | $14M | |
| Capital Leases | $3M | $969.0K | $2M | |
| Total Liabilities | $289M | $77M | $16M | |
| Long-term Debt | $47M | · | · | |
| Total Debt | $6M | $6M | · | |
| Common Stock | $1.42B | $1.37B | $948M | |
| Retained Earnings | $-1.12B | $-911M | $-343M | |
| AOCI | $-187.0K | $573.0K | $181.0K | |
| Stockholders' Equity | $306M | $464M | $605M | |
| Liabilities + Equity | $595M | $541M | $621M | |
| Shares Outstanding | 346,503,675 | 337,837,872 | 219,046,219 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $683.0K | $222.0K | |
| Stock-based Comp | $36M | $32M | $20M | |
| Operating Cash Flow | $-173M | $-130M | $-68M | |
| Investing Cash Flow | $100M | $123M | $9M | |
| Financing Cash Flow | $203M | $331.0K | $628.0K | |
| Net Change in Cash | $128M | $-7M | $-58M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | · | 10.1% | · | |
| Operating Margin | -338.7% | -7527.3% | · | |
| Net Margin | -325.3% | -7213.8% | · | |
| Pretax Margin | -325.3% | -7213.8% | · | |
| EBITDA Margin | -338.7% | -7527.3% | · | |
| ROA | -36.0% | -97.7% | · | |
| ROE | -60.3% | -117.5% | · | |
| ROIC | -68.4% | -126.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.0 | 9.0 | · | |
| Quick Ratio | 6.4 | 8.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.90 | $1.37 | · | |
| Revenue / Share | $184.17 | $29.29 | · | |
| Cash Flow / Share | $-507.78 | $-485.22 | · | |
| Cash / Share | $0.49 | $0.11 | · | |
| EPS (TTM) | $-0.60 | $-2.11 | $-0.35 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 699.0% | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $63M | $8M | $0 | |
| Net Income TTM | $-205M | $-568M | $-76M | |
| Market Cap | $3.03B | $899M | · | |
| Enterprise Value | $2.50B | $402M | · | |
| P/E | -14.9 | -1.3 | -4.3 | |
| P/S | 48.1 | 114.1 | · | |
| P/B | 9.9 | 1.9 | · | |
| P / Tangible Book | 10.3 | 2.0 | 0.5 | |
| P / Cash Flow | -17.5 | -6.9 | · | |
| EV / EBITDA | -11.8 | -0.7 | · | |
| EV / Revenue | 39.8 | 51.1 | · | |
| Earnings Yield | -6.7% | -79.3% | -23.2% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32M | $83M | $42M | $13M | $5M | $3M | $6M | $727.0K | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | · | $3M | $3M | $2M | · | $2M | $1M | $0 | · | · | · | |
| Gross Profit | · | · | · | $10M | $2M | $990.0K | · | $-788.0K | $88.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $31M | $35M | $34M | $29M | $27M | $25M | $29M | $28M | $29M | $13M | $15M | $19M | $19M | |
| SG&A Expense | $43M | $38M | $40M | $37M | $38M | $35M | $26M | $20M | $16M | $7M | $5M | $8M | $8M | |
| Operating Expenses | $83M | $79M | $84M | $66M | $68M | $62M | $63M | $47M | $470M | $20M | $21M | $26M | $26M | |
| Operating Income | $-51M | $4M | $-34M | $-56M | $-64M | $-59M | $-54M | $-48M | $-470M | $-20M | $-21M | $-26M | $-26M | |
| Interest Expense | · | · | · | $5M | · | · | · | · | $132.0K | · | · | · | $0 | |
| Other Non-op | $-12M | $2M | $-9M | $642.0K | $5M | $6M | $-20M | $7M | $8M | $5M | $7M | $7M | $5M | |
| Pretax Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| EPS (Basic) | $-0.18 | $0.02 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| EPS (Diluted) | $-0.18 | $0.01 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| Shares (Basic) | 348,770 | 347,332 | · | 342,393 | 340,746 | 338,612 | · | 273,565 | 244,738 | 219,048 | · | 218,935 | 218,848 | |
| Shares (Diluted) | 348,770 | 377,521 | · | 342,393 | 340,746 | 338,612 | · | 273,565 | 244,738 | 219,048 | · | 218,935 | 218,848 | |
| EBITDA | $-51M | $4M | · | $-56M | $-64M | $-59M | · | $-48M | $-470M | $-20M | · | $-26M | $-26M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $259M | $125M | $164M | $99M | $248M | $48M | $36M | $30M | $34M | $35M | $43M | $24M | $50M | |
| Short-term Investments | $402M | $408M | $365M | $450M | $360M | $414M | $467M | $519M | $543M | $562M | $569M | $595M | $581M | |
| Inventory | $20M | $16M | $11M | $6M | $552.0K | $14.0K | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $14M | $16M | $12M | $9M | $8M | $8M | $7M | $12M | $6M | $7M | $2M | $3M | $4M | |
| Current Assets | $726M | $592M | $572M | $578M | $623M | $476M | $526M | $565M | $587M | $608M | $616M | $625M | $637M | |
| PP&E (Net) | $715.0K | $535.0K | $564.0K | $560.0K | $615.0K | $562.0K | $586.0K | $719.0K | $751.0K | $686.0K | $717.0K | $764.0K | $804.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $971.0K | $874.0K | $839.0K | $782.0K | · | $666.0K | · | · | |
| Intangibles | $10M | $11M | $11M | $12M | $12M | $4M | $5M | $3M | $3M | · | $0 | · | · | |
| Other Non-current Assets | $4M | $4M | $8M | $7M | $7M | $7M | $7M | $480.0K | $1M | $1M | $587.0K | $587.0K | · | |
| Total Assets | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Accounts Payable | $12M | $22M | $9M | $15M | $22M | $11M | $6M | $12M | $5M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $45M | $33M | $45M | $33M | $24M | $24M | $33M | $24M | $20M | $11M | $10M | $12M | $10M | |
| Short-term Debt | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $8M | $12M | · | $0 | · | · | |
| Current Liabilities | $87M | $80M | $82M | $68M | $66M | $53M | $58M | $59M | $51M | $16M | $14M | $16M | $13M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $4M | $969.0K | $985.0K | $972.0K | $2M | $2M | $3M | $2M | |
| Total Liabilities | $491M | $291M | $289M | $276M | $274M | $73M | $77M | $69M | $63M | $19M | $16M | $19M | $17M | |
| Long-term Debt | $243M | $47M | $47M | $47M | $47M | · | · | · | · | · | · | · | · | |
| Total Debt | $6M | $6M | · | $6M | $6M | $6M | · | $8M | $12M | · | · | · | · | |
| Common Stock | $1.43B | $1.43B | $1.42B | $1.40B | $1.40B | $1.38B | $1.37B | $1.36B | $1.08B | $953M | $948M | $944M | $938M | |
| Retained Earnings | $-1.17B | $-1.11B | $-1.12B | $-1.08B | $-1.02B | $-964M | $-911M | $-861M | $-820M | $-358M | $-343M | $-329M | $-309M | |
| AOCI | $-3M | $-2M | $-187.0K | $-139.0K | $-327.0K | $545.0K | $573.0K | $1M | $-1M | $-1M | $181.0K | $-3M | $-4M | |
| Stockholders' Equity | $254M | $320M | $306M | $326M | $373M | $419M | $464M | $503M | $257M | $594M | $605M | $612M | $625M | |
| Liabilities + Equity | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Shares Outstanding | 346,503,675 | 346,503,675 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 336,248,642 | 248,624,729 | 219,083,219 | 219,046,219 | 218,944,053 | 218,899,462 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $536.0K | $536.0K | $539.0K | $534.0K | $356.0K | $310.0K | $219.0K | $162.0K | $244.0K | $58.0K | $55.0K | $55.0K | $56.0K | |
| Stock-based Comp | $10M | $9M | $8M | $8M | $12M | $8M | $10M | $7M | $10M | $5M | $4M | $5M | $6M | |
| Operating Cash Flow | $-43M | $5M | $-30M | $-53M | $-48M | $-43M | $-46M | $-31M | $-37M | $-16M | $-15M | $-16M | $-17M | |
| Investing Cash Flow | $6M | $-44M | $87M | $-97M | $55M | $54M | $52M | $29M | $34M | $8M | $33M | $-10M | $37M | |
| Financing Cash Flow | $171M | $44.0K | $8M | $501.0K | $193M | $548.0K | $-900.0K | $-2M | $3M | $21.0K | $120.0K | $77.0K | $133.0K | |
| Net Change in Cash | $133M | $-39M | $65M | $-149M | $200M | $12M | $6M | $-4M | $-225.0K | $-8M | $18M | $-26M | $20M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 74.5% | 46.7% | 32.1% | · | -108.4% | 6.1% | · | · | · | · | |
| Operating Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| Net Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| Pretax Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| EBITDA Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| ROA | -9.0% | 0.98% | · | -9.5% | -9.5% | -9.6% | · | -6.9% | -74.8% | -2.3% | · | -3.0% | -3.0% | |
| ROE | -20.1% | 1.5% | · | -13.5% | -18.7% | -10.5% | · | -7.4% | -104.9% | -2.4% | · | -3.1% | -3.1% | |
| ROIC | -19.7% | 1.2% | · | -17.0% | -16.8% | -13.9% | · | -9.4% | -175.0% | -3.4% | · | -4.3% | -4.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 7.4 | · | 8.5 | 9.4 | 9.0 | · | 9.6 | 11.5 | 38.6 | · | 38.7 | 47.5 | |
| Quick Ratio | 7.6 | 6.7 | · | 8.1 | 9.2 | 8.7 | · | 9.3 | 11.3 | 37.9 | · | 38.4 | 47.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | -11.0 | · | · | · | · | -3563.5 | · | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | · | · | · | 1.2 | 9.3 | 299.1 | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.73 | $0.92 | · | $0.96 | $1.10 | $1.24 | · | $1.50 | $1.03 | $2.71 | · | $2.79 | $2.85 | |
| Revenue / Share | $90.85 | $220.46 | · | $38.32 | $14.18 | $9.11 | · | $2.66 | $5.86 | · | · | · | · | |
| Cash Flow / Share | · | $13.43 | · | · | · | $-125.89 | · | · | · | $-71.68 | · | · | · | |
| Cash / Share | $0.75 | $0.36 | · | $0.29 | $0.73 | $0.14 | · | $0.09 | $0.14 | $0.16 | · | $0.11 | $0.23 | |
| EPS (TTM) | $-0.44 | $-0.43 | · | $-0.49 | $-0.48 | $-2.20 | · | $-2.18 | $-2.12 | $-0.32 | · | $-0.38 | $-0.41 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $143M | · | $27M | $14M | $11M | · | $2M | $1M | $0 | · | · | · | |
| Net Income TTM | $-150M | $-146M | · | $-217M | $-203M | $-606M | · | $-532M | $-511M | $-69M | · | $-83M | $-90M | |
| Market Cap | $1.97B | $1.49B | · | $1.25B | $659M | $595M | · | $770M | $726M | $797M | · | $293M | $394M | |
| Enterprise Value | $1.31B | $959M | · | $707M | $57M | $139M | · | $229M | $160M | · | · | · | · | |
| P/E | -12.9 | -10.0 | · | -7.6 | -4.1 | -0.8 | · | -1.1 | -1.4 | -11.4 | · | -3.5 | -4.4 | |
| P/S | 11.6 | 10.4 | · | 46.7 | 45.9 | 54.3 | · | 356.2 | 505.9 | · | · | · | · | |
| P/B | 7.8 | 4.7 | · | 3.8 | 1.8 | 1.4 | · | 1.5 | 2.8 | 1.3 | · | 0.5 | 0.6 | |
| P / Tangible Book | 8.1 | 4.8 | · | 4.0 | 1.8 | 1.4 | · | 1.5 | 2.9 | 1.3 | · | 0.5 | 0.6 | |
| P / Cash Flow | · | 293.3 | · | · | · | -13.9 | · | · | · | -50.8 | · | · | · | |
| EV / Revenue | 7.7 | 6.7 | · | 26.4 | 3.9 | 12.6 | · | 106.1 | 111.8 | · | · | · | · | |
| Earnings Yield | -7.8% | -10.0% | · | -13.2% | -24.6% | -125.0% | · | -95.2% | -72.6% | -8.8% | · | -28.4% | -22.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $63M | $8M | $0 | · | · |
| Bruttogewinnmarge % | · | 10.1% | · | · | · |
| Betriebsgewinnmarge % | -338.7% | -7527.3% | · | · | · |
| Nettoergebnis | $-205M | $-568M | $-76M | $-104M | $-87M |
| Verwässerte EPS | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.0 | · | · | · |
| Liquiditätsgrad | 7.0 | 9.0 | · | 50.7 | 45.6 |
| Quick Ratio | 6.4 | 8.6 | · | 50.2 | 45.2 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 257 Einreicher · $1.5B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
257
Gehaltener Wert
$1.5B
Neue Positionen
39
Geschlossene Positionen
25
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 39 (-9 vs. Vorquartal) | 25 (-8 vs. Vorquartal) | 108 (+20 vs. Vorquartal) | 55 (-6 vs. Vorquartal) | +17.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $296.668.075 | 52.230.295 | 20,30% | Aktien |
| BlackRock, Inc. | $156.943.154 | 27.630.837 | 10,74% | Aktien |
| Decheng Capital LLC | $147.421.214 | 25.954.439 | 10,09% | Aktien |
| VANGUARD GROUP INC | $139.378.229 | 15.555.606 | 9,54% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.702.840 | 11.919.514 | 4,63% | Aktien |
| Omega Fund Management, LLC | $45.900.586 | 8.081.089 | 3,14% | Aktien |
| Laurion Capital Management LP | $44.417.674 | 7.820.013 | 3,04% | Aktien |
| STATE STREET CORP | $41.866.110 | 7.370.794 | 2,86% | Aktien |
| UBS Group AG | $36.208.324 | 6.374.705 | 2,48% | Kaufoption |
| GEODE CAPITAL MANAGEMENT, LLC | $35.477.953 | 6.244.805 | 2,43% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $25.557.979 | 4.499.643 | 1,75% | Aktien |
| BANK OF AMERICA CORP /DE/ | $20.048.969 | 3.529.748 | 1,37% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $18.741.484 | 3.299.557 | 1,28% | Aktien |
| Redmile Group, LLC | $17.216.131 | 3.031.009 | 1,18% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $15.271.623 | 2.688.666 | 1,05% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $13.384.517 | 2.356.429 | 0,92% | Aktien |
| NORTHERN TRUST CORP | $13.188.238 | 2.321.873 | 0,90% | Aktien |
| ALGERT GLOBAL LLC | $12.935.393 | 2.277.358 | 0,89% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.694.382 | 2.058.870 | 0,80% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $11.631.936 | 2.047.876 | 0,80% | Aktien |
| ARMISTICE CAPITAL, LLC | $11.360.000 | 2.000.000 | 0,78% | Aktien |
| CITADEL ADVISORS LLC | $11.293.715 | 1.988.330 | 0,77% | Aktien |
| GOLDMAN SACHS GROUP INC | $10.818.616 | 1.904.686 | 0,74% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $10.090.827 | 1.776.554 | 0,69% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $9.978.738 | 1.756.820 | 0,68% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $9.211.176 | 1.621.686 | 0,63% | Aktien |
| Knoll Capital Management, LLC | $9.079.996 | 1.598.591 | 0,62% | Aktien |
| MORGAN STANLEY | $8.277.652 | 1.457.333 | 0,57% | Aktien |
| Jump Financial, LLC | $7.715.774 | 1.358.411 | 0,53% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.645.252 | 1.345.995 | 0,52% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $7.531.278 | 1.344.871 | 0,52% | Aktien |
| FIRST TRUST ADVISORS LP | $7.397.274 | 1.302.337 | 0,51% | Aktien |
| ABRAMS CAPITAL MANAGEMENT, L.P. | $7.216.463 | 1.270.504 | 0,49% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.090.963 | 1.248.409 | 0,49% | Aktien |
| NewEdge Advisors, LLC | $6.996.243 | 1.231.733 | 0,48% | Aktien |
| D. E. Shaw & Co., Inc. | $6.475.200 | 1.140.000 | 0,44% | Aktien |
| UBS Group AG | $6.343.884 | 1.116.881 | 0,43% | Aktien |
| Nuveen, LLC | $6.155.007 | 1.083.628 | 0,42% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.802.268 | 1.021.526 | 0,40% | Aktien |
| Woodline Partners LP | $5.541.022 | 975.532 | 0,38% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.195.945 | 914.779 | 0,36% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $4.065.637 | 715.781 | 0,28% | Aktien |
| Bank of New York Mellon Corp | $3.803.823 | 669.687 | 0,26% | Aktien |
| Beacon Pointe Advisors, LLC | $3.591.186 | 632.251 | 0,25% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.522.176 | 393.100 | 0,24% | Aktien |
| Invesco Ltd. | $3.336.387 | 587.392 | 0,23% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.037.431 | 534.759 | 0,21% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $2.953.600 | 520.000 | 0,20% | Aktien |
| JPMORGAN CHASE & CO | $2.893.055 | 515.696 | 0,20% | Aktien |
| Swiss National Bank | $2.765.024 | 486.800 | 0,19% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Claudio Nessi, Otello Stampacchia ×3 Einreichungen | 18. Oktober 2024 | · | Erste Einreichung | · | SEC |
| Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Decheng Anbio Limited, Xiangmin Cui | 10. September 2024 | · | Erste Einreichung | Vorstandskampagne | SEC |
| David Hung, M.D. ×2 Einreichungen | 26. März 2024 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 12 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Junyuan Jerry Wang | CEO, ANHEART THERAPEUTICS LTD. | 11. November 2024 S | 3.866.228 | 0 | 0 | $0 |
| Philippe Sauvage | Chief Financial Officer | 15. Juli 2026 M | 54.131 | 0 | 1 | $-286.485 |
| Jennifer A. Fox | Chief Financial Officer | 28. Februar 2023 A | · | 0 | 0 | $0 |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 19. August 2026 M | 0 | 0 | 4 | $-3.879.239 |
| Stacy Markel | CHIEF PEOPLE OFFICER | 23. Juni 2026 M | 32.591 | 0 | 1 | $-753.750 |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 23. Juni 2026 M | 53.000 | 0 | 3 | $-1.467.378 |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 17. April 2026 M | 18.000 | 0 | 7 | $-1.866.900 |
| Colleen Sjogren | Chief Commercial Officer | 27. Februar 2026 A | 81.000 | 0 | 0 | $0 |
| Moses Makunje | Title: VP, Finance and principal financial and accounting officer. | 27. Februar 2026 A | 68.137 | 0 | 0 | $0 |
| David C. Hanley | CHIEF TECHNICAL OPERATIONS | 27. Februar 2026 A | 24.000 | 0 | 1 | $-1.428.000 |
| Sergey Yurasov | Chief Medical Officer | 10. Februar 2021 A | · | 0 | 0 | $0 |
| Thomas Templeman | SVP, Pharmaceutical Ops | 10. Februar 2021 A | · | 0 | 0 | $0 |
| Robert Mashal | Direktor | 9. Juni 2026 P | 225.000 | 1 | 0 | $118.250 |
| Robert B Bazemore | Direktor | 21. Mai 2026 A | 5.000 | 0 | 0 | $0 |
| Xiangmin Cui | Direktor | 21. Mai 2026 A | 17.062.202 | 0 | 0 | $0 |
| Kathryn E Falberg | Direktor | 21. Mai 2026 A | 250.000 | 0 | 0 | $0 |
| Daniel G Welch | Direktor | 24. Mai 2024 M | 659.947 | 0 | 0 | $0 |
| Oleg Nodelman | Direktor | 29. Oktober 2021 A | · | 0 | 0 | $0 |
| Graham K Cooper | Direktor | 10. Februar 2021 M | 25.000 | 0 | 0 | $0 |
| Shalini Sharp | Direktor | 10. Februar 2021 M | 35.000 | 0 | 0 | $0 |
| Faheem Hasnain | Direktor | 10. Februar 2021 M | 55.000 | 0 | 0 | $0 |
| Daniel Bradbury | Direktor | 10. Februar 2021 M | 25.000 | 0 | 0 | $0 |
| Anthony W Vernon | · | 21. Mai 2026 A | 304.100 | 0 | 0 | $0 |
| Kim D Blickenstaff | · | 21. Mai 2026 A | 172.189 | 0 | 0 | $0 |
| David Hung | · | 27. Februar 2026 A | 59.281.054 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 38 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,77% | 275.843 NS | 31. Juli 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,57% | 51.286 NS | 31. Juli 2026 | N-PORT |
| IDNA · iShares Trust | 1,51% | 613.529 SH | 11. September 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 1,20% | 732.575 SH | 23. Oktober 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,44% | 909.498 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,37% | 855.978 SH | 11. September 2026 | Täglich |
| IHE · iShares Trust | 0,35% | 902.180 SH | 11. September 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,32% | 265.449 SH | 23. Oktober 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,21% | 460.740 NS | 31. Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,18% | 10.233 NS | 31. Juli 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,12% | 237.789 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,12% | 1.891.272 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,10% | 2.370.008 SH | 11. September 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 82.391 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 270.228 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 218.055 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,05% | 6.449.970 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,05% | 120.391 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 201.792 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1.450.662 SH | 19. August 2026 | Täglich |
| TECB · iShares Trust | 0,03% | 24.294 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 163.106 SH | 23. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 115.286 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.787.165 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 730.126 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 430.890 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 13.480 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 405.885 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.055 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 70.393 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 310.102 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 5.348 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 37.633 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 8.849.329 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19.595 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 10.466 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 51.844 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 88.212 SH | 11. September 2026 | Täglich |
NUVB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$12.00
+162,6%
5 26,3%
Starker Kauf
12 63,2%
Kauf
2 10,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-10-23Mittelwert-Ziel $13.00 +184,5%
← Unter allen Zielen
Aktueller Preis $4.57
Tief$7.00
Mittelwert$13.00
Hoch$21.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026